Cryopreserved amniotic membrane in the treatment of diabetic foot ulcers: a case series.

Objective: The amniotic membrane (AM) is a tissue with low immunogenity and high therapeutic potential due to its anti-inflammatory, anti-fibrotic and antimicrobial effects. This paper describes the use of cryopreserved amniotic membrane allografts to treat diabetic foot ulcers (DFUs) in patients with diabetes.

Method: In this case series, AM was processed to obtain a final medicinal product: cryopreserved amniotic membrane.